CU6 3.45% $6.59 clarity pharmaceuticals ltd

Research/Valuation, page-376

  1. 27 Posts.
    lightbulb Created with Sketch. 47
    Zero hostility here - apologies if it came across that way

    I think the capital raise was overhanging the fusion M&A otherwise we would have broken $3 back then. Given the contact book the CEO has I'd imagine he would have had plenty of inbound questions on whether Clarity would like institutional money to strengthen the balance sheet as opposed to them buying on the open market. Last week, any prospective buyers knew they had only one choice if they wanted a large holding...

    I also think the poster news release no doubt helped too. Whatever the reason, I agree let's hope for more of the same this week!

    Last edited by Tapples: 05/05/24
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.